Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

The challenge of improved secretory production of active pharmaceutical ingredients in Saccharomyces cerevisiae: a case study on human insulin analogs.

Kazemi Seresht A, Palmqvist EA, Schluckebier G, Pettersson I, Olsson L.

Biotechnol Bioeng. 2013 Oct;110(10):2764-74. doi: 10.1002/bit.24928. Epub 2013 Apr 26.

PMID:
23592021
[PubMed - indexed for MEDLINE]
2.

Long-term adaptation of Saccharomyces cerevisiae to the burden of recombinant insulin production.

Kazemi Seresht A, Cruz AL, de Hulster E, Hebly M, Palmqvist EA, van Gulik W, Daran JM, Pronk J, Olsson L.

Biotechnol Bioeng. 2013 Oct;110(10):2749-63. doi: 10.1002/bit.24927. Epub 2013 May 14.

PMID:
23568816
[PubMed - indexed for MEDLINE]
3.

Modulating heterologous protein production in yeast: the applicability of truncated auxotrophic markers.

Kazemi Seresht A, Nørgaard P, Palmqvist EA, Andersen AS, Olsson L.

Appl Microbiol Biotechnol. 2013 May;97(9):3939-48. doi: 10.1007/s00253-012-4263-1. Epub 2012 Jul 11.

PMID:
22782252
[PubMed - indexed for MEDLINE]
4.

The impact of phosphate scarcity on pharmaceutical protein production in S. cerevisiae: linking transcriptomic insights to phenotypic responses.

Kazemi Seresht A, Palmqvist EA, Olsson L.

Microb Cell Fact. 2011 Dec 7;10:104. doi: 10.1186/1475-2859-10-104.

PMID:
22151908
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Fed-batch cultivation of baker's yeast followed by nitrogen or carbon starvation: effects on fermentative capacity and content of trehalose and glycogen.

Jørgensen H, Olsson L, Rønnow B, Palmqvist EA.

Appl Microbiol Biotechnol. 2002 Jul;59(2-3):310-7. Epub 2002 May 1.

PMID:
12111163
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk